Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer

pharmafile | July 7, 2020 | News story | Manufacturing and Production Purdue, opioid, opioid crisis 

Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He was 65.

Jonathan served as an executive board member for Purdue but had recently stepped down, while retaining his ownership of the company. He had also been Vice President in the past, but was not as involved as his brother Richard who was Chief Executive.

Multiple lawsuits named Jonathan as a defendant where the prosecution accused the Sackler family of marketing OxyContin, an opioid painkiller, in ways that misled patients with how addictive it could be.

Purdue Pharma has played a key role in the widespread opioid epidemic. They filed for bankruptcy back in September, as part of a deal to settle thousands of lawsuits alleging the company misled doctors and the public as it promoted opioids like OxyContin. An exposed 1997 email chain shows Dr Richard Sackler knew about the potential abuse of opioids by its clients.

Purdue has also agreed to provide more than $10 billion to address the opioid crisis, with the Sackler family personally promising to contribute a minimum of $3 billion. It has also converted itself in to a public beneficiary trust.

Conor Kavanagh

Related Content


Johnson & Johnson to contribute a further $1 billion to US opioid settlement

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the …

Photo by Psiĥedelisto

Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus

Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to …


New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in …

Latest content